ROCKET PHARMACEUTICALS, INC.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Restricted Stock Units
The following table summarizes the Company’s RSU activity for the three months ended March 31, 2026:
| Weighted Average | ||
|---|---|---|
| Number of | Grant Date | |
| Shares | Fair Value | |
| Unvested as of December 31, 2025 | 5,000,566 | $6.51 |
| Granted | 3,685,796 | 4.36 |
| Vested(1) | (803,054) | 9.30 |
| Forfeited | (185,105) | 7.04 |
| Unvested as of March 31, 2026 | 7,698,203 | $5.18 |
(1) Common stock issued excludes 834 awards that were vested in 2025 but issued in 2026.
The total fair value of RSUs vested during the three months ended March 31, 2026 and 2025 was$7.3 million and$7.3 million, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.